English | Español
Press release submission | Apr 14, 2018

MASSACHUSETTS GENERAL HOSPITAL: RB1 gene mutations underlie clinical resistance to CDK 4/6 inhibitor therapy for breast cancer
Press release submission | Apr 14, 2018

NATIONAL INSTITUTES OF HEALTH: New biological research framework for Alzheimer’s to spur discovery
Press release submission | Apr 14, 2018

UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Findings Flip Scientists' Understanding of Key Growth Switch Involved in Cancer
Press release submission | Apr 13, 2018

AMERICAN HEART ASSOCIATION: Caregiving costs expected to more than double, analysis finds
Press release submission | Apr 13, 2018

UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Smoking Cessation Therapies Do Not Raise Cardiovascular Risk
Press release submission | Apr 13, 2018

NATIONAL INSTITUTE OF HEALTH: NIH scientists develop macaque model to study Crimean-Congo hemorrhagic fever
Press release submission | Apr 13, 2018

CLEVELAND CLINIC: Many Infants are Fed Complimentary Foods Too Young
Press release submission | Apr 13, 2018

MASSACHUSETTS GENERAL HOSPITAL: Party Lines

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'